학술논문
The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice
Document Type
Article
Author
Source
In European Journal of Surgical Oncology May 2021 47(5):1191-1195
Subject
Language
ISSN
0748-7983